Federal contract award
75A50324F80002
EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING TAMIFLU 75MG CAPSULES (NDC 0004-0800-85) AND TAMIFLU 30MG CAPSULES (NDC 0004-0802-85)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79723D0219 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Nov 17, 2023 |
| Current end date | Nov 16, 2025 |
| Potential end date | Nov 16, 2025 |
| Latest award activity | Dec 16, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 16, 2024 | P00001 | $-397.0M | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI TERMINATION FOR CONVENIENCE AGREEMENT AND CLOSEOUT MODIFICATION |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.